Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M17,033Revenue $M4,617Net Margin (%)10.9Altman Z-Score4.9
Enterprise Value $M18,543EPS $1.1Operating Margin %16.3Piotroski F-Score4
P/E(ttm)62.7Beneish M-Score-2.9Pre-tax Margin (%)15.5Higher ROA y-yN
Price/Book4.210-y EBITDA Growth Rate %13.1Quick Ratio1.0Cash flow > EarningsY
Price/Sales6.95-y EBITDA Growth Rate %2.5Current Ratio2.0Lower Leverage y-yN
Price/Free Cash Flow37.2y-y EBITDA Growth Rate %-27.7ROA % (ttm)7.0Higher Current Ratio y-yN
Dividend Yield %2.5PEG25.5ROE % (ttm)12.2Less Shares Outstanding y-yN
Payout Ratio %73.0Shares Outstanding M476ROIC % (ttm)9.5Gross Margin Increase y-yY

Gurus Latest Trades with SNN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNNDavid Dreman 2015-06-30 Reduce-0.04%$33.68 - $35.8
($34.72)
$ 35.823%Reduce 11.73%103,704
SNNKen Fisher 2015-06-30 Reduce-0.02%$33.68 - $35.8
($34.72)
$ 35.823%Reduce 9.42%2,083,106
SNNMario Gabelli 2015-06-30 Reduce$33.68 - $35.8
($34.72)
$ 35.823%Reduce 75.36%6,375
SNNDavid Dreman 2015-03-31 Reduce-0.09%$33.44 - $36.85
($35.39)
$ 35.821%Reduce 21.04%117,479
SNNKen Fisher 2015-03-31 Add$33.44 - $36.85
($35.39)
$ 35.821%Add 0.35%2,299,852
SNNMario Gabelli 2015-03-31 Reduce$33.44 - $36.85
($35.39)
$ 35.821%Reduce 18.82%25,875
SNNKen Fisher 2014-09-30 Reduce-0.07%$33.164 - $36.18
($34.9)
$ 35.823%Reduce 28.52%2,432,882
SNNMario Gabelli 2014-09-30 Add$33.164 - $36.18
($34.9)
$ 35.823%Add 59.07%38,375
SNNDavid Dreman 2014-09-30 Reduce$33.164 - $36.18
($34.9)
$ 35.823%Reduce 0.74%185,812
SNNKen Fisher 2014-06-30 Add0.07%$29.268 - $38.908
($32.7)
$ 35.8210%Add 36.95%3,403,562
SNNDavid Dreman 2014-06-30 Reduce-0.02%$29.268 - $38.908
($32.7)
$ 35.8210%Reduce 4.15%187,192
SNNMario Gabelli 2014-06-30 Buy 0.0045%$29.268 - $38.908
($32.7)
$ 35.8210%New holding24,125
SNNDavid Dreman 2014-03-31 Add0.07%$28.336 - $32.072
($30.24)
$ 35.8218%Add 17.20%195,295
SNNKen Fisher 2014-03-31 Reduce-0.01%$28.336 - $32.072
($30.24)
$ 35.8218%Reduce 5.85%2,485,278
SNNDavid Dreman 2013-12-31 Reduce-0.22%$24.02 - $28.74
($26.41)
$ 35.8236%Reduce 37.34%166,635
SNNKen Fisher 2013-12-31 Add$24.02 - $28.74
($26.41)
$ 35.8236%Add 0.72%2,639,815
SNNDavid Dreman 2013-09-30 Add0.04%$22.404 - $25.224
($24.14)
$ 35.8248%Add 6.56%265,928
SNNKen Fisher 2013-09-30 Reduce$22.404 - $25.224
($24.14)
$ 35.8248%Reduce 0.12%2,620,952
SNNDavid Dreman 2013-06-30 Add$21.932 - $24.068
($23.17)
$ 35.8255%Add 12.73%249,552
SNNKen Fisher 2013-06-30 Add$21.932 - $24.068
($23.17)
$ 35.8255%Add 0.69%2,624,032
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SNN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about SNN :

Quarterly/Annual Reports about SNN:

    News about SNN:

    Articles On GuruFocus.com
    Sintana Energy Reports Manati Blanco-1 Well Drilling Progress-To-Date and Provides Operations Update Aug 04 2015 
    Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 
    Sintana Energy Reports on Execution of Drilling Rig Contract Dec 11 2014 
    3 Dividend Kings From The U.K. I Love To Buy Aug 21 2014 
    Stryker Corporation (SYK) Dividend Stock Analysis Jan 11 2013 
    5 Highly Predictable Mid-/Large-Caps with ROC Over 15% Apr 21 2012 
    The Best Dividends on April 18, 2012 Apr 18 2012 
    5 Healthcare Stocks to Consider Today Mar 21 2012 
    medical Feb 29 2012 
    Stryker Corp. (SYK) Dividend Stock Analysis Dec 16 2011 

    More From Other Websites
    Presentation of the half-year report for the first Semester of 2015 Aug 14 2015
    Is GlaxoSmithKline plc A Better Buy Than Smith & Nephew plc And Hikma Pharmaceuticals Plc? Aug 13 2015
    Current report on the initiation of the share capital increase procedure of SNN with contributions... Aug 12 2015
    Current report regarding the convening of the Ordinary General Meeting of Shareholders for... Aug 12 2015
    Dallas private equity firm backs Fort Worth loft development Jul 30 2015
    Should You Invest In Bonmarche Holdings PLC, Smith & Nephew plc And BT Group plc After Today’s... Jul 30 2015
    Smith & Nephew posts earnings beat on knee, wound care growth Jul 30 2015
    Appointment of Robin Freestone as Non-Executive Director Jul 30 2015
    Second Quarter Trading and First Half 2015 Results Jul 30 2015
    Medical technology firm to 'streamline operations' with new $35M facility Jul 28 2015
    The operation of Cernavoda NPP within normal parameters despite the decrease of the level of the... Jul 22 2015
    Smith & Nephew acquires Russian distribution and manufacturing business Jul 10 2015
    Smith & Nephew buys Russian manufacturing business Jul 10 2015
    Smith & Nephew buys Russian manufacturing business Jul 10 2015
    Smith & Nephew upgraded by Berenberg Jul 09 2015
    Britain's FTSE lifted by gains in mining stocks Jul 09 2015
    Smith & Nephew to Partner with Scopis on “Next Generation” Target Guided Surgical Technology... Jul 07 2015
    The Wound Institute® Website Receives Bronze Stevie® Award in 2015 American Business Awards(SM) Jun 25 2015
    Medical-Device Maker Zimmer Narrows Revenue Projection Jun 24 2015
    Smith & Nephew to acquire Zimmer’s Unicondylar Knee system in US market Jun 24 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK